UniProt ID | AACT_HUMAN | |
---|---|---|
UniProt AC | P01011 | |
Protein Name | Alpha-1-antichymotrypsin | |
Gene Name | SERPINA3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 423 | |
Subcellular Localization | Secreted. | |
Protein Description | Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.. | |
Protein Sequence | MERMLPLLALGLLAAGFCPAVLCHPNSPLDEENLTQENQDRGTHVDLGLASANVDFAFSLYKQLVLKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTLNQSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQDSAAAKKLINDYVKNGTRGKITDLIKDLDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNASALFILPDQDKMEEVEAMLLPETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTSKADLSGITGARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
27 | Phosphorylation | AVLCHPNSPLDEENL HHHCCCCCCCCHHHC | 31.15 | 24505115 | |
33 | N-linked_Glycosylation | NSPLDEENLTQENQD CCCCCHHHCCCCCCC | 46.47 | 16335952 | |
33 | N-linked_Glycosylation | NSPLDEENLTQENQD CCCCCHHHCCCCCCC | 46.47 | 17623646 | |
35 | Phosphorylation | PLDEENLTQENQDRG CCCHHHCCCCCCCCC | 45.48 | 26657352 | |
93 | N-linked_Glycosylation | FLSLGAHNTTLTEIL HHHHCCCCCCHHHHH | 33.94 | 17623646 | |
93 | N-linked_Glycosylation | FLSLGAHNTTLTEIL HHHHCCCCCCHHHHH | 33.94 | 17623646 | |
106 | N-linked_Glycosylation | ILKGLKFNLTETSEA HHHHCCCCCCCCCHH | 44.45 | 12754519 | |
106 | N-linked_Glycosylation | ILKGLKFNLTETSEA HHHHCCCCCCCCCHH | 44.45 | 18638581 | |
127 | N-linked_Glycosylation | QHLLRTLNQSSDELQ HHHHHHHCCCCCHHC | 38.79 | 18638581 | |
127 | N-linked_Glycosylation | QHLLRTLNQSSDELQ HHHHHHHCCCCCHHC | 38.79 | 16335952 | |
158 | Acetylation | DRFTEDAKRLYGSEA HHHHHHHHHHHCCHH | 56.08 | 12438997 | |
177 | Acetylation | FQDSAAAKKLINDYV CCCHHHHHHHHHHHH | 43.30 | 12439007 | |
186 | N-linked_Glycosylation | LINDYVKNGTRGKIT HHHHHHHHCCCCCHH | 47.20 | 17623646 | |
186 | N-linked_Glycosylation | LINDYVKNGTRGKIT HHHHHHHHCCCCCHH | 47.20 | 16335952 | |
191 | Acetylation | VKNGTRGKITDLIKD HHHCCCCCHHHHHHH | 38.86 | 19814787 | |
201 | Phosphorylation | DLIKDLDSQTMMVLV HHHHHCCHHHHHHHH | 34.54 | 25003641 | |
203 | Phosphorylation | IKDLDSQTMMVLVNY HHHCCHHHHHHHHHH | 15.93 | 25003641 | |
210 | Phosphorylation | TMMVLVNYIFFKAKW HHHHHHHHHHHHHCC | 7.51 | 28851738 | |
226 | Phosphorylation | MPFDPQDTHQSRFYL CCCCCCCCCCHHEEC | 19.30 | 29083192 | |
229 | Phosphorylation | DPQDTHQSRFYLSKK CCCCCCCHHEECCCC | 19.42 | 29083192 | |
235 | Acetylation | QSRFYLSKKKWVMVP CHHEECCCCCEEEEE | 56.64 | 81933 | |
236 | Acetylation | SRFYLSKKKWVMVPM HHEECCCCCEEEEEC | 48.79 | 81935 | |
237 | Acetylation | RFYLSKKKWVMVPMM HEECCCCCEEEEECC | 49.08 | 81937 | |
245 | Phosphorylation | WVMVPMMSLHHLTIP EEEEECCCCCCCCCC | 20.49 | 24505115 | |
261 | S-nitrosylation | FRDEELSCTVVELKY CCCCCCCEEEEEEEE | 5.38 | 25040305 | |
271 | N-linked_Glycosylation | VELKYTGNASALFIL EEEEECCCCEEEEEE | 23.95 | 16335952 | |
271 | N-linked_Glycosylation | VELKYTGNASALFIL EEEEECCCCEEEEEE | 23.95 | 18638581 | |
273 | Phosphorylation | LKYTGNASALFILPD EEECCCCEEEEEECC | 29.51 | - | |
295 | Phosphorylation | EAMLLPETLKRWRDS HHHHCHHHHHHHHHH | 35.32 | 20363803 | |
302 | Phosphorylation | TLKRWRDSLEFREIG HHHHHHHHHCHHHCC | 22.64 | 23911959 | |
312 | Phosphorylation | FREIGELYLPKFSIS HHHCCCEECCCCEEC | 19.36 | 25690035 | |
338 | Phosphorylation | LGIEEAFTSKADLSG HCCHHHHCCCCHHCC | 36.04 | - | |
347 | Phosphorylation | KADLSGITGARNLAV CCHHCCCCCCHHHHH | 28.45 | 24505115 | |
347 | O-linked_Glycosylation | KADLSGITGARNLAV CCHHCCCCCCHHHHH | 28.45 | 46286157 | |
355 | Phosphorylation | GARNLAVSQVVHKAV CCHHHHHHHHHHHHH | 16.20 | 24505115 | |
370 | Phosphorylation | LDVFEEGTEASAATA HHHHHHCCHHHHHHH | 31.49 | 24505115 | |
373 | Phosphorylation | FEEGTEASAATAVKI HHHCCHHHHHHHHHH | 16.53 | 24505115 | |
373 | O-linked_Glycosylation | FEEGTEASAATAVKI HHHCCHHHHHHHHHH | 16.53 | OGP | |
381 | O-linked_Glycosylation | AATAVKITLLSALVE HHHHHHHHHHHHHHH | 18.87 | OGP | |
381 | Phosphorylation | AATAVKITLLSALVE HHHHHHHHHHHHHHH | 18.87 | 24505115 | |
384 | Phosphorylation | AVKITLLSALVETRT HHHHHHHHHHHHCCH | 23.75 | 24505115 | |
389 | Phosphorylation | LLSALVETRTIVRFN HHHHHHHCCHHHCCC | 26.15 | 24505115 | |
389 | O-linked_Glycosylation | LLSALVETRTIVRFN HHHHHHHCCHHHCCC | 26.15 | OGP | |
416 | Acetylation | QNIFFMSKVTNPKQA CCEEEEECCCCCCCC | 41.09 | 7782318 | |
421 | Acetylation | MSKVTNPKQA----- EECCCCCCCC----- | 62.01 | 7782318 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AACT_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AACT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AACT_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RPA12_HUMAN | ZNRD1 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93; ASN-106; ASN-127 ANDASN-271, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-33; ASN-93; ASN-106;ASN-127; ASN-186 AND ASN-271, AND MASS SPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-93, AND MASS SPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-93 AND ASN-106. |